Sarah Cattin

Sarah Cattin is a Researcher in the Department of Oncology, Microbiology and Immunology (OMI) at the Faculty of Science and Medicine, University of Fribourg. Her work focuses on cancer biology, immunology, and cellular interactions, with a particular emphasis on colorectal and breast cancers. She is affiliated with institutes such as IMF and NARA within the faculty.

Her research interests include understanding mechanisms of cancer progression, immune response modulation, and developing therapeutic strategies. She has contributed to studies on three-dimensional tumor models, immune cell dynamics in cancer therapy, and the role of inflammatory pathways in tumorigenesis.

Publications highlight her work on flow cytometry analysis of immune populations, emodin’s anti-cancer effects, and fibroblast-driven cancer cell migration. No specific awards or grants are listed, but her involvement in collaborative research is evident through co-authored papers. She is part of the Medicine Section at the University of Fribourg, contributing to both research and academic activities.